{"protocolSection":{"identificationModule":{"nctId":"NCT04724824","orgStudyIdInfo":{"id":"SALUD-2018-02-B-S-45803"},"organization":{"fullName":"Instituto Nacional de Rehabilitacion","class":"OTHER_GOV"},"briefTitle":"Validation of a Brain-Computer Interface for Stroke Neurological Upper Limb Rehabilitation","officialTitle":"Validation of a Brain-Computer Interface for Neurorehabilitation With a Randomized Controlled Trial (Validación de Una Interfaz Cerebro-Computadora Para Rehabilitación Neurológica Por Medio de un Ensayo Clínico Controlado y Aleatorizado)"},"statusModule":{"statusVerifiedDate":"2023-02","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-03-16","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2021-01-22","studyFirstSubmitQcDate":"2021-01-22","studyFirstPostDateStruct":{"date":"2021-01-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-02-17","lastUpdatePostDateStruct":{"date":"2023-02-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Jessica Cantillo-Negrete","investigatorTitle":"Researcher in Medical Sciences","investigatorAffiliation":"Instituto Nacional de Rehabilitacion"},"leadSponsor":{"name":"Instituto Nacional de Rehabilitacion","class":"OTHER_GOV"},"collaborators":[{"name":"National Council of Science and Technology, Mexico","class":"OTHER"},{"name":"Hospital General Dr. Manuel Gea González","class":"OTHER_GOV"},{"name":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study's main goal is to determine if clinical and physiological effects of a brain-computer interface intervention for the neurorehabilitation of stroke patients' upper limb are greater than the effects of a sham robotic feedback. For this purpose a randomized controlled trial will be performed to compare somatosensory sham robotic feedback with the same somatosensory feedback controlled with the brain-computer interface output."},"conditionsModule":{"conditions":["Stroke, Ischemic","Stroke"],"keywords":["brain-computer interface","robotic orthosis","hemiparesis","motor rehabilitation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":40,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Brain-Computer Interface controlled robotic feedback","type":"EXPERIMENTAL","interventionNames":["Device: Brain-Computer Interface"]},{"label":"Sham Brain-Computer Interface controlled robotic feedback","type":"SHAM_COMPARATOR","interventionNames":["Device: Sham Brain-Computer Interface"]}],"interventions":[{"type":"DEVICE","name":"Brain-Computer Interface","description":"Passive hand movement will be provided to patients' paralyzed hand by means of a robotic hand orthosis that will be activated by the brain-computer interface based on hand movement intention.","armGroupLabels":["Brain-Computer Interface controlled robotic feedback"]},{"type":"DEVICE","name":"Sham Brain-Computer Interface","description":"Passive hand movement will be provided to patients' paralyzed hand by means of a robotic hand orthosis which activation will be independent of the output of the brain-computer interface based on hand movement intention.","armGroupLabels":["Sham Brain-Computer Interface controlled robotic feedback"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Mean change from baseline in upper limb motor function on the Fugl-Meyer Assessment for the Upper Extremity","description":"Analysis of changes on the Fugl-Meyer Assessment for the Upper Extremity will reveal if there is a clinical significant sensorimotor function compared to baseline","timeFrame":"At enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset"},{"measure":"Mean change from baseline in upper limb motor function on the Action Research Arm Test","description":"Analysis of changes on the Action Research Arm Test will reveal if there is a clinical significant motor function compared to baseline","timeFrame":"At enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset"}],"secondaryOutcomes":[{"measure":"Mean change from baseline in cortical activity measured with Functional Magnetic Resonance Imaging","description":"Blood-oxygen-level-dependent imaging will be analyzed to assess if there are changes in cortical activity compared to baseline.","timeFrame":"At enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset"},{"measure":"Mean change from baseline in corticospinal excitability measured with Transcranial Magnetic Stimulation","description":"Motor Evoked Potentials parameters will reveal if there are changes of corticospinal excitability in both hemibodies compared to baseline","timeFrame":"At enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset"},{"measure":"Mean change from baseline in grip strength measured with a dynamometer","description":"Analysis of hand strength measurements will reveal if there were changes compared to baseline","timeFrame":"At enrollment, 3 weeks after the intervention onset, 6 weeks after the intervention onset, and 24 weeks after the intervention onset"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical diagnosis of first ischemic stroke\n* Time since stroke onset higher than 3 months and lower than 24 months\n* Hand paresis\n* Normal or corrected to normal vision\n* Without previous diagnosed neurological diseases\n\nExclusion Criteria:\n\n* Clinical diagnosis of severe aphasia\n* Clinical diagnosis of severe depression\n* Clinical diagnosis of severe attention deficits\n* Previous diagnosis of traumatic brain injury\n* Previous diagnosis of spinal cord injury\n* Previous diagnosis of peripheral nerve injury","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Jessica Cantillo-Negrete, PhD","role":"CONTACT","phone":"+52 55 59991000","phoneExt":"19008","email":"jcantillo@inr.gob.mx"},{"name":"Jimena Quinzaños-Fresnedo, PhD","role":"CONTACT","phone":"+52 55 59991000","phoneExt":"13410","email":"jimenaquinzanos@gmail.com"}],"overallOfficials":[{"name":"Jessica Cantillo-Negrete, PhD","affiliation":"Instituto Nacional de Rehabilitacion (National Institute of Rehabilitation)","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra (National Institute of Rehabilitation)","status":"RECRUITING","city":"Tlalpan","state":"Mexico City","zip":"14389","country":"Mexico","contacts":[{"name":"Jessica Cantillo-Negrete, PhD","role":"CONTACT","phone":"+52 55 59991000","phoneExt":"19008","email":"jcantillo@inr.gob.mx"},{"name":"Ruben I. Carino-Escobar, PhD","role":"CONTACT","phone":"+52 55 59991000","phoneExt":"19007","email":"ricarino@inr.gob.mx"},{"name":"Jessica Cantillo-Negrete, PhD","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Ruben I. Carino-Escobar, PhD","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":19.29513,"lon":-99.16206}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"De-identified individual participant data collected during the study will be available to other researchers from the principal investigator on reasonable request.","infoTypes":["CSR"],"timeFrame":"Six months after publication","accessCriteria":"Researchers that make a request for access data and their request is approved by the National Institute of Rehabilitation Ethics Committee"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}